News

The new website and app were born out of a partnership with Apple, the CDC, the White House Coronavirus Task Force and FEMA.

Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.

Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.

The simple finger-prick test will be made available first to NHS staff.

The new functionalities on the ManulifeMOVE platform will be made available from May 2020.   

CU Healthcare Innovation Fund led the Series A round. 

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Yesterday MassChallenge hosted a summit on innovation in the age of the coronavirus crisis, and panelists discussed how providers are implementing new digital programs into their toolbox. 

The firm is also offering a hospital avoidance solution to provide care to patients with underlying respiratory conditions.

The association has also created a virtual panel discussion to talk best practices when using the tech for telemedicine.